Skip to content

About us

Quthero is a private company advancing regenerative therapies based on its proprietary Q-peptide technology for applications in dermatology and cardiology. Q-peptide is a synthetic, bioactive, peptide sequence derived from Angiopoietin-1, with documented regenerative and anti-inflammatory properties.

Q-peptide platform enables versatile applications in areas where cell survival, anti-inflammatory effects, and regenerative support are critical. Quthero’s pipeline focuses on applications of post-aesthetic procedures, wound healing and regeneration, and cardiovascular health.

Program engagement

Leadership

Milica Radisic

Founder & CEO

Omar Ibrahimi

Chief Medical Director

Status

Intellectual Property

Fundraising

In Market

Sector

Subsector

i.d.e.a. Fund Applications Open

Applications are now open for i.d.e.a. Fund Cohort 4

Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?

The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.

Applications are open from June 16 to July 7, 2025.